Company: CRLBF
Filing Date: 2025-08-20
Form Type: SC TO-I
Source: 0001832928-25-000022
Chunk: 4

Company: Cresco Labs Inc.
Filing Date: 2025-08-20
Form: SC TO-I
Chunk 4
---
 by reference.

(b) Securities Transactions . The information set forth under Section 9 (“ Interests of Directors and Executive Officers; Transactions and Arrangements Concerning Our Securities ”) of the Offering Memorandum is incorporated herein by reference.

## ITEM 9. Persons/Assets, Retained, Employed, Compensated or Used.
(a) Solicitations or Recommendations . Not applicable.

## ITEM 10. Financial Statements.
(a) Financial Information. The information set forth under Section 8 (“ Information Concerning Cresco Labs; Financial Information ”) and Section 15 (“ Additional Information ”) of the Offering Memorandum is incorporated herein by reference.

(b) Pro Forma Information . Not applicable.

## ITEM 11. Additional Information.
(a) Agreements, Regulatory Requirements and Legal Proceedings . The information set forth under Section 9 (“ Interests of Directors and Executive Officers; Transactions and Arrangements Concerning Our Securities ”) and Section 11 (“ Legal Matters; Regulatory Approvals ”) of the Offering Memorandum is incorporated herein by reference.

(c) Other Material Information . The information set forth in the Offer to Exchange, as may be amended or supplemented from time to time, is incorporated herein by reference. The Company will amend this Schedule TO to include documents that the Company may file with the SEC after the date of the Offer to Exchange pursuant to Section 13(a), 13(c) or 14 of the Exchange Act and prior to the expiration of the Exchange Offer to the extent required by Rule 13e-4(d)(2) promulgated under the Exchange Act. The information contained in all of the exhibits referred to in Item 12 below is incorporated herein by reference.

The Company intends to conduct the Exchange Offer solely for compensatory purposes and will rely on the SEC’s March 13, 2001, “Exemptive Order” (Exchange Act Release No. 34-44062) granting no-action relief for compensatory equity-award exchange programs. By relying on that Exemptive Order, the Company is permitted to limit the offer to a specified group of employees (rather than all holders of a class of options) and provide differentiated exchange terms without violating the “all-holders” and “best-price” requirements of Rule 13e-4 of the Exchange Act.

## ITEM 12. Exhibits.
| Exhibit Number |     | Description                                                                                                                                                                                           |
| (a)(1)(A)      |     | Offer to Exchange Eligible Options for New Awards, dated August 20,